Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development
Chronic noncommunicable diseases represent one of the key medical problems of the XXI century. In this group cardiovascular diseases (CVD) are known to be the leading cause of death which pathogenesis still has the potential to be more profoundly revealed in order to discover its yet unknown but ess...
Main Authors: | O. M. Drapkina, A. N. Kaburova |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2020-05-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2159 |
Similar Items
-
Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
by: Martina Belli, et al.
Published: (2023-07-01) -
Gut microbiota in heart failure and related interventions
by: An‐Tian Chen, et al.
Published: (2023-08-01) -
Gut microbiota – a new companion on the path of cardiovascular diseases progression: surprising roles of long-time neighbors
by: O. M. Drapkina, et al.
Published: (2016-03-01) -
Impact of Gut Microbiota on the Risk of Cardiometabolic Diseases Development
by: L. E. Vasilyeva, et al.
Published: (2021-11-01) -
Causal impact of gut microbiota and associated metabolites on pulmonary arterial hypertension: a bidirectional Mendelian randomization study
by: Xin Li, et al.
Published: (2024-04-01)